Reveleer, a Glendale, CA-based healthcare technology data and analytics company, has recently announced a significant milestone in its growth journey, securing over $65 million in funding. The financing round was led by Hercules Capital, highlighting the continued investor confidence in Reveleer’s mission and potential.

CEO and President of Reveleer, Jay Ackerman, expressed enthusiasm about the impact of this funding, stating, “This funding will have a tremendous impact as it positions us to strategically pursue inorganic growth opportunities in value-based-care technology, accelerating innovation and enhancing patient care through healthcare AI technology.”

Reveleer specializes in AI-powered solutions tailored to the healthcare industry, offering comprehensive workflow, data management, and analytics platforms. Through the integration of natural language processing (NLP) and artificial intelligence (AI), the company empowers health plans and risk-bearing providers to streamline operations, improve quality of care, and optimize financial performance.

The recent investment will fuel Reveleer’s strategic expansion efforts, enabling the company to scale its offerings for both payers and providers. This includes enhancing its suite of solutions for Prospective Risk Adjustment, Quality Improvement, and Member Management, ultimately contributing to the advancement of value-based care objectives nationwide.

Noteworthy acquisitions have played a pivotal role in Reveleer’s growth trajectory. In 2022, the company acquired Dynamic Healthcare Systems, broadening its integrated workflow platform to include member management, revenue optimization, and HCC Analytics. The subsequent acquisition of MDPortals in 2023 further strengthened Reveleer’s position, providing a prospective risk platform that facilitates the closing of care gaps at the point of care, thereby improving health outcomes.

Reveleer’s commitment to driving innovation and addressing critical challenges within the healthcare landscape has garnered recognition and support from investors. The recent funding infusion, combined with previous investments, underscores the company’s dedication to revolutionizing healthcare delivery through advanced technology and data-driven solutions.

As Reveleer continues to expand its offerings and reach, stakeholders in the healthcare ecosystem can anticipate enhanced capabilities and outcomes, ultimately contributing to the improvement of patient care and overall system efficiency.